- First interim Phase 2 data of an IL-23p19 antagonist in pediatric patients - New analysis from the pivotal Phase 3 LUCENT-1 and LUCENT-2 studies INDIANAPOLIS, May 9, 2023 /PRNewswire/ -- Eli...

Industry Veteran Brings 24 Years Experience Across All Aspects of Compliance to Firm's Large and Complex Consulting Assignments Latest Addition Joins Team Prior to Firm's Participation as...

Lam Research Corp. (Nasdaq: LRCX) today announced that Doug Bettinger, Executive Vice President and Chief Financial Officer, will participate in the following upcoming investor event: JP Morgan...

Revenues of $77.4 million, decreased 8% sequentially, and increased 25% year-over-year Enterprise revenues of $35.7 million, up 11% sequentially, and increased 130% year-over-year Gross margin of...

Families and dog lovers from all over Chicagoland can enjoy great family-friendly entertainment (at an accessible value) and the thrill of world-class canine competition at the upcoming Great...